BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16100687)

  • 1. BIO-1211 (Biogen).
    Bolger GT
    IDrugs; 2000 May; 3(5):536-40. PubMed ID: 16100687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-0991 (Merck & Co).
    Groll AH; Walsh TJ
    IDrugs; 1999 Nov; 2(11):1201-12. PubMed ID: 16113992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iloperidone (Novartis).
    Hesselink JM
    IDrugs; 2002 Jan; 5(1):84-90. PubMed ID: 12861482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GMK (Progenics Pharmaceuticals).
    Knutson KL
    Curr Opin Investig Drugs; 2002 Jan; 3(1):159-64. PubMed ID: 12054067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natalizumab: AN 100226, anti-4alpha integrin monoclonal antibody.
    Drugs R D; 2004; 5(2):102-7. PubMed ID: 15293871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eculizumab (Alexion).
    Kaplan M
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1017-23. PubMed ID: 12186261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDP-02 (Millenium).
    Marshall JK
    Curr Opin Investig Drugs; 2001 Apr; 2(4):502-4. PubMed ID: 11566006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retigabine (ASTA Medica).
    Fatope MO
    IDrugs; 2001 Jan; 4(1):93-8. PubMed ID: 16034707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostatin (EntreMed).
    Grosios K
    IDrugs; 2000 Jul; 3(7):799-810. PubMed ID: 16080055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD18 mAb (Genentech/Roche).
    Brown WM
    IDrugs; 2000 Aug; 3(8):953-60. PubMed ID: 16059812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zanamivir (Glaxo Wellcome).
    Oxford JS
    IDrugs; 2000 Apr; 3(4):447-59. PubMed ID: 16100701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repinotan Bayer.
    Lutsep HL
    Curr Opin Investig Drugs; 2002 Jun; 3(6):924-7. PubMed ID: 12137415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azelnidipine (Sankyov KK).
    Khanna JM
    IDrugs; 1999 Aug; 2(8):807-13. PubMed ID: 16127657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADL-2-1294 (Adolor).
    Wheeler GD
    IDrugs; 2000 Nov; 3(11):1373-8. PubMed ID: 16047259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-0139 (Shionogi).
    Wu-Wong JR
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1051-6. PubMed ID: 12186266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dronedarone (Sanofi-Synthélabo).
    Le Grand B
    IDrugs; 2001 May; 4(5):582-5. PubMed ID: 16012904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
    Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
    Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hu1124 (Genentech).
    Granlund H
    IDrugs; 2000 Oct; 3(10):1229-34. PubMed ID: 16049845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tifacogin (Chiron Corp/Pharmacia Corp).
    Sne N; Ondiveeran HK; Fox-Robichaud A
    IDrugs; 2002 Jan; 5(1):91-7. PubMed ID: 12861483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.